Scarica l'app Stockscreener
1.33
1.53%
0.02
Dopo l'orario di chiusura:
1.34
0.01
+0.75%
Precedente Chiudi:
$1.31
Aprire:
$1.3
Volume 24 ore:
937.15K
Relative Volume:
0.80
Capitalizzazione di mercato:
$254.96M
Reddito:
$156.37M
Utile/perdita netta:
$-37.49M
Rapporto P/E:
-6.3333
EPS:
-0.21
Flusso di cassa netto:
$-47.77M
1 W Prestazione:
+1.53%
1M Prestazione:
+2.31%
6M Prestazione:
-15.82%
1 anno Prestazione:
-36.97%
Intervallo 1D:
$1.265
$1.34
Intervallo di 1 settimana:
$1.265
$1.34
Portata 52W:
$1.12
$2.235
Cerus Corp Stock (CERS) Company Profile
Nome
Cerus Corp
Settore
Industria
Telefono
(925) 288-6000
Indirizzo
1220 CONCORD AVENUE, CONCORD, CA
Confronta CERS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CERS
Cerus Corp
|
1.33 | 243.46M | 156.37M | -37.49M | -47.77M | -0.21 |
|
ABT
Abbott Laboratories
|
132.81 | 228.80B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.29 | 158.04B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.34 | 149.08B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.85 | 119.71B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
80.96 | 48.01B | 5.69B | 1.41B | 577.90M | 6.95 |
Cerus Corp Stock (CERS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-04-12 | Iniziato | Craig Hallum | Buy |
| 2023-01-20 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-01-17 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2020-10-08 | Ripresa | BTIG Research | Buy |
| 2020-06-16 | Ripresa | Cantor Fitzgerald | Overweight |
| 2020-02-26 | Iniziato | BTIG Research | Buy |
| 2019-11-13 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2019-08-28 | Iniziato | Stifel | Buy |
| 2019-08-23 | Ripresa | Stephens | Overweight |
| 2018-01-05 | Ripresa | Cantor Fitzgerald | Overweight |
| 2017-12-08 | Ripresa | BTIG Research | Neutral |
| 2016-07-07 | Ripresa | Cantor Fitzgerald | Buy |
| 2015-12-17 | Downgrade | Wedbush | Outperform → Neutral |
| 2014-05-02 | Reiterato | MLV & Co | Buy |
| 2013-04-24 | Reiterato | Cantor Fitzgerald | Buy |
| 2013-03-15 | Reiterato | MLV & Co | Buy |
| 2012-04-17 | Iniziato | Cantor Fitzgerald | Buy |
| 2012-02-29 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2011-11-10 | Reiterato | MLV & Co | Buy |
| 2011-06-03 | Iniziato | Wedbush | Outperform |
| 2011-03-04 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2010-03-09 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2009-08-26 | Aggiornamento | Avondale | Mkt Perform → Mkt Outperform |
Mostra tutto
Cerus Corp Borsa (CERS) Ultime notizie
News impact scoring models applied to Cerus Corporation2025 Top Decliners & Entry Point Confirmation Alerts - Newser
Published on: 2025-09-04 00:35:06 - Newser
Forecasting Cerus Corporation price range with options dataProduct Launch & Safe Entry Zone Tips - Newser
What are Cerus Corporation’s technical support levelsPortfolio Update Summary & High Conviction Trade Alerts - khodrobank.com
Is Cerus Corporation stock a value trapQuarterly Profit Report & Risk Controlled Stock Alerts - khodrobank.com
Using data filters to optimize entry into Cerus Corporation2025 Trade Ideas & Stepwise Trade Signal Implementation - Newser
Cerus at Cantor Global Healthcare: Strategic Growth and Market Expansion - Investing.com
Sentiment analysis tools applied to Cerus Corporation2025 Analyst Calls & Risk Adjusted Swing Trade Ideas - Newser
How to build a custom watchlist for Cerus CorporationEarnings Risk Report & Fast Gain Stock Tips - Newser
What earnings revisions data tells us about Cerus CorporationFed Meeting & Smart Money Movement Tracker - Newser
Evaluating Cerus Corporation with trendline analysisMarket Risk Summary & Safe Capital Growth Trade Ideas - Newser
Published on: 2025-09-03 05:39:40 - Newser
What momentum shifts mean for Cerus Corporation2025 Market Outlook & Stepwise Entry and Exit Trade Signals - Newser
How to escape a deep drawdown in Cerus CorporationMarket Sentiment Summary & AI Optimized Trading Strategy Guides - Newser
Custom watchlist performance reports with Cerus CorporationAnalyst Upgrade & Free Expert Verified Stock Movement Alerts - Newser
Trend analysis for Cerus Corporation this weekEarnings Risk Summary & Short-Term Trading Alerts - Newser
Can volume confirm reversal in Cerus CorporationTrade Risk Report & Daily Stock Trend Reports - Newser
Predicting Cerus Corporation trend using moving averagesJuly 2025 PostEarnings & Daily Price Action Insights - Newser
Chart overlay techniques for tracking Cerus CorporationJuly 2025 Closing Moves & Daily Momentum Trading Reports - Newser
What high frequency data says about Cerus CorporationMarket Volume Summary & Low Risk Profit Maximizing Plans - Newser
Guidance Update: Is Cerus Corporation undervalued by DCF analysisRecession Risk & Precise Trade Entry Recommendations - khodrobank.com
Is this a good reentry point in Cerus CorporationInflation Watch & Risk Controlled Stock Pick Alerts - Newser
Technical analysis overview for Cerus Corporation stockJuly 2025 PostEarnings & Daily Price Action Insights - Newser
Smart tools for monitoring Cerus Corporation’s price actionWeekly Stock Analysis & Free Safe Capital Growth Stock Tips - Newser
Charles Schwab Investment Management Inc. Raises Stock Holdings in Cerus Corporation $CERS - Defense World
Analyzing drawdowns of Cerus Corporation with statistical tools2025 Dividend Review & Free Expert Verified Stock Movement Alerts - Newser
Will Cerus Corporation bounce back from current support2025 EndofYear Setup & Daily Risk Controlled Trade Plans - Newser
Is now the right time to enter Cerus CorporationOptions Play & Precise Entry and Exit Recommendations - sundaytimes.kr
Cerus Corp Azioni (CERS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Cerus Corp Azioni (CERS) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Jensen Chrystal | Chief Legal Officer |
Mar 14 '25 |
Sale |
1.45 |
30,075 |
43,609 |
783,294 |
| Jensen Chrystal | Chief Legal Officer |
Mar 13 '25 |
Sale |
1.45 |
18,949 |
27,476 |
813,369 |
| Jayaraman Vivek K | Chief Operating Officer |
Mar 14 '25 |
Sale |
1.45 |
46,004 |
66,706 |
1,431,326 |
| Jayaraman Vivek K | Chief Operating Officer |
Mar 13 '25 |
Sale |
1.45 |
29,985 |
43,478 |
1,477,330 |
| Greenman William Mariner | President and CEO |
Mar 14 '25 |
Sale |
1.45 |
122,827 |
178,099 |
4,115,845 |
| Greenman William Mariner | President and CEO |
Mar 13 '25 |
Sale |
1.45 |
71,086 |
103,075 |
4,238,672 |
| Green Kevin Dennis | Chief Financial Officer |
Mar 14 '25 |
Sale |
1.45 |
36,740 |
53,273 |
875,867 |
| Green Kevin Dennis | Chief Financial Officer |
Mar 13 '25 |
Sale |
1.45 |
23,147 |
33,563 |
912,607 |
| Benjamin Richard J | Chief Medical Officer |
Mar 14 '25 |
Sale |
1.45 |
30,075 |
43,609 |
685,775 |
| Benjamin Richard J | Chief Medical Officer |
Mar 13 '25 |
Sale |
1.45 |
18,949 |
27,476 |
715,850 |
0.38%
0.32%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):